Precigen Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Others were interested in
See all stocksFrequently asked questions
To buy Precigen Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Precigen Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Precigen Inc. is PGEN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Precigen Inc. has its primary listing on NASDAQ. You can trade Precigen Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Precigen Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Precigen Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Precigen Inc..